Antipsychotic-induced tardive dyskinesia and the Ser9Gly polymorphism in the DRD3 gene: A meta analysis

被引:86
作者
Bakker, PR
van Harten, PN
van Os, J
机构
[1] Psychiat Hosp Symfora Grp, Amersfoort, Netherlands
[2] Maastricht Univ, S Limburg Mental Hlth Res & Teaching Network, Dept Psychiat & Neuropsychol, Maastricht, Netherlands
[3] Maastricht Univ, S Limburg Mental Hlth Res & Teaching Network, Dept Psychiat & Neuropsychol, Maastricht, Netherlands
[4] Inst Psychiat, Div Psychol Med, London, England
关键词
(genetic) polymorphism; extrapyramidal (syndrome/disorder); tardive dyskinesia; drug-induced; antipsychotic; dopamine; 3; receptor;
D O I
10.1016/j.schres.2006.01.010
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: A polymorphic site in the gene encoding the dopamine 3 receptor (DRD3) resulting in a serine (Set) into glycine (Gly) substitution has been shown to affect dopamine binding affinity, and may contribute to individual differences in susceptibility to antipsychotic-induced tardive dyskinesia (TD). Methods: A Medline, EMBASE and PsychINFO search of literature published between 1976 and March 2005 yielded 11 studies from which data were extracted for calculation of pooled estimates using meta-analytic techniques. Results: The Gly allele increased the risk relative to the Ser allele (OR = 1.17; 95% CI: 1.01-1.37) with evidence of publication bias. No significant genotype effects were apparent. Conclusions: TD may be associated with functional variation in the DRD3 allele. However, caution is required in interpreting this finding, as there is evidence of publication bias, genetic methodology has shortcomings, and the relation between antipsychotics, schizophrenia and TD is complex. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:185 / 192
页数:8
相关论文
共 50 条
[1]   A targeted mutation of the D-3 dopamine receptor gene is associated with hyperactivity in mice [J].
Accili, D ;
Fishburn, CS ;
Drago, J ;
Steiner, H ;
Lachowicz, JE ;
Park, BH ;
Gauda, EB ;
Lee, EJ ;
Cool, MH ;
Sibley, DR ;
Gerfen, CR ;
Westphal, H ;
Fuchs, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (05) :1945-1949
[2]   Pharmacogenomics in schizophrenia: the quest for individualized therapy [J].
Basile, VS ;
Masellis, M ;
Potkin, SG ;
Kennedy, JL .
HUMAN MOLECULAR GENETICS, 2002, 11 (20) :2517-2530
[3]   Association of the MscI polymorphism of the dopamine D3 receptor gene with tardive dyskinesia in schizophrenia [J].
Basile, VS ;
Masellis, M ;
Badri, F ;
Paterson, AD ;
Meltzer, HY ;
Lieberman, JA ;
Potkin, SG ;
Macciardi, F ;
Kennedy, JL .
NEUROPSYCHOPHARMACOLOGY, 1999, 21 (01) :17-27
[4]   Polymorphisms of dopamine receptors and tardive dyskinesia among Chinese patients with schizophrenia [J].
Chong, SA ;
Tan, EC ;
Tan, CH ;
Mythily ;
Chan, YH .
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2003, 116B (01) :51-54
[5]   Lower risk for tardive dyskinesia associated with second-generation antipsychotics: A systematic review of 1-year studies [J].
Correll, CU ;
Leucht, S ;
Kane, JM .
AMERICAN JOURNAL OF PSYCHIATRY, 2004, 161 (03) :414-425
[6]  
Friedman JH, 2004, J CLIN PSYCHIAT, V65, P3
[7]  
Gaitonde EJ, 1996, AM J MED GENET, V67, P455, DOI 10.1002/(SICI)1096-8628(19960920)67:5<455::AID-AJMG3>3.0.CO
[8]  
2-J
[9]   Dopamine D3 receptor gene and tardive dyskinesia in Chinese schizophrenic patients [J].
Garcia-Barceló, MM ;
Lam, LCW ;
Ungvari, GS ;
Lam, VKL ;
Tang, WK .
JOURNAL OF NEURAL TRANSMISSION, 2001, 108 (06) :671-677
[10]  
GLAZER WM, 1994, HOSP COMMUNITY PSYCH, V45, P38